Robotic Surgery Executives Sell Millions in Stock

Several executives at US robotic surgery company Intuitive Surgical, Inc. (NASDAQ: ISRG) recently sold shares under pre-established 10b5-1 trading plans.

On June 1, Da Vinci platform executive Iman Jeddi exercised stock options to acquire common shares and then sold the same number at about $420 per share, generating total proceeds of approximately $2.4 million (roughly 3 billion KRW).

Between May 18 and 20, manufacturing and supply chain executive Mark Brozious disposed of small lots—several dozen shares each day—and on June 10, General Counsel and Chief Compliance Officer Gary Loeb sold 400 shares at about $424 per share, for total proceeds of about $169,700 (around 240 million KRW). All transactions were carried out under existing trading plans and reduced only a portion of each executive’s total holdings.

Meanwhile, at the end of May the company announced over 100 upgrades to its da Vinci 5 surgical robot, simulation platform and remote collaboration capabilities, with a phased rollout in the US beginning in June.

In its fiscal 2026 first-quarter earnings report filed in April, Intuitive Surgical noted that both robotic surgery case volumes and system installations grew by double-digit percentages year-over-year. Net income rose to $822 million (about 1.1 trillion KRW), up from $698 million in the same quarter last year.

Headquartered in Sunnyvale, California, Intuitive Surgical specializes in robotic surgical systems and supplies its da Vinci minimally invasive surgical platform to hospitals worldwide. Leveraging its installed base of surgical robots, the company generates recurring revenue from instruments, consumables and services, and, as a Nasdaq-listed major healthcare firm, it continues to lead the robot-assisted surgery market.